4552 JCR Pharmaceuticals Co.,Ltd.JCRファーマTSE Prime / Pharmaceuticals
0 posts
JCR Pharmaceuticals Co.,Ltd. (4552) at a glance
Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.
JCR Pharmaceuticals Co.,Ltd. (4552) Stock Price History
JCR Pharmaceuticals Co.,Ltd. closed at ¥480 on Nov 20, 2026, −8.0% over 1 month, −24.4% over 1 year.
If you had invested ¥100,000 1 month ago, it would be worth ¥91,954 today (−8.0%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −11.9%, while this stock moved −8.0%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥480 | −14 | −2.83% |
| Nov 19 (Thu) | ¥494 | −2 | −0.40% |
| Nov 18 (Wed) | ¥496 | −4 | −0.80% |
| Nov 17 (Tue) | ¥500 | −5 | −0.99% |
| Nov 16 (Mon) | ¥505 | +6 | +1.20% |
| Nov 13 (Fri) | ¥499 | +6 | +1.22% |
| Nov 12 (Thu) | ¥493 | +0 | +0.00% |
| Nov 11 (Wed) | ¥493 | −11 | −2.18% |
| Nov 10 (Tue) | ¥504 | +8 | +1.61% |
| Nov 9 (Mon) | ¥496 | +8 | +1.64% |
If you had invested ¥100,000 3 months ago, it would be worth ¥87,912 today (−12.1%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −14.8%, while this stock moved −12.1%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 20 (Fri) | ¥480 | −14 | −2.83% |
| Nov 19 (Thu) | ¥494 | −2 | −0.40% |
| Nov 18 (Wed) | ¥496 | −4 | −0.80% |
| Nov 17 (Tue) | ¥500 | −5 | −0.99% |
| Nov 16 (Mon) | ¥505 | +6 | +1.20% |
| Nov 13 (Fri) | ¥499 | +6 | +1.22% |
| Nov 12 (Thu) | ¥493 | +0 | +0.00% |
| Nov 11 (Wed) | ¥493 | −11 | −2.18% |
| Nov 10 (Tue) | ¥504 | +8 | +1.61% |
| Nov 9 (Mon) | ¥496 | +8 | +1.64% |
If you had invested ¥100,000 6 months ago, it would be worth ¥97,363 today (−2.6%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved −5.6%, while this stock moved −2.6%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥480 | −11.8% |
| Oct 2026 | ¥544 | +8.4% |
| Sep 2026 | ¥502 | −4.0% |
| Aug 2026 | ¥523 | +9.2% |
| Jul 2026 | ¥479 | +3.5% |
| Jun 2026 | ¥463 | −6.8% |
| May 2026 | ¥497 | −9.0% |
If you had invested ¥100,000 1 year ago, it would be worth ¥75,591 today (−24.4%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +13.3%, while this stock moved −24.4%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | ¥480 | −11.8% |
| Oct 2026 | ¥544 | +8.4% |
| Sep 2026 | ¥502 | −4.0% |
| Aug 2026 | ¥523 | +9.2% |
| Jul 2026 | ¥479 | +3.5% |
| Jun 2026 | ¥463 | −6.8% |
| May 2026 | ¥497 | −9.0% |
| Apr 2026 | ¥546 | −3.9% |
| Mar 2026 | ¥568 | −18.2% |
| Feb 2026 | ¥694 | +7.6% |
| Jan 2026 | ¥645 | −9.4% |
| Dec 2025 | ¥712 | −9.1% |
| Nov 2025 | ¥783 | ― |
If you had invested ¥100,000 3 years ago, it would be worth ¥36,725 today (−63.3%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +67.8%, while this stock moved −63.3%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥480 | −32.6% |
| 2025 | ¥712 | ― |
If you had invested ¥100,000 5 years ago, it would be worth ¥18,838 today (−81.2%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +96.3%, while this stock moved −81.2%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥480 | −32.6% |
| 2025 | ¥712 | ― |
If you had invested ¥100,000 in Dec 2005, it would be worth ¥281,113 today (+181.1%).Price change only; dividends and fees are not included.
Over the same period the Nikkei 225 moved +250.3%, while this stock moved +181.1%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | ¥480 | −32.6% |
| 2025 | ¥712 | +17.3% |
| 2024 | ¥607 | −48.2% |
| 2023 | ¥1,172 | −30.3% |
| 2022 | ¥1,681 | −24.4% |
| 2021 | ¥2,224 | −8.7% |
| 2020 | ¥2,437 | +10.0% |
| 2019 | ¥2,215 | +90.3% |
| 2018 | ¥1,164 | −12.3% |
| 2017 | ¥1,328 | +86.3% |
| 2016 | ¥713 | +7.8% |
| 2015 | ¥661 | +12.5% |
| 2014 | ¥588 | +3.1% |
| 2013 | ¥570 | +80.3% |
| 2012 | ¥316 | +65.4% |
| 2011 | ¥191 | −28.7% |
| 2010 | ¥268 | +4.4% |
| 2009 | ¥257 | +156.4% |
| 2008 | ¥100 | −17.3% |
| 2007 | ¥121 | −3.0% |
| 2006 | ¥125 | −26.8% |
| 2005 | ¥171 | ― |
Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Dec 2005). Please check the latest prices before trading.
JCR Pharmaceuticals Co.,Ltd. (4552) financial indicators
PER, ROE and dividend yield are based on company forecasts, calculated from earnings reports and the closing price after each trading day.
Key features of JCR Pharmaceuticals Co.,Ltd. (4552)
Business overview
The company manufactures, purchases and sells prescription drugs, regenerative medicine products and pharmaceutical raw materials. Its group includes ArmaGen, which develops drugs and manages intellectual property and licenses; subsidiaries handling clinical operations, regulatory affairs and development in Brazil and Europe; and AlliedCel, which researches, develops, makes and sells regenerative medicine products. It has a drug development partnership with Medipal Holdings.
Summarized from the annual securities report (fiscal year ended March 2026) filed on EDINET.
Position within Pharmaceuticals (79 companies)
| Dividend yield | 4.17% | No. 5 in the sector (highest first); median 2.97% |
|---|---|---|
| PER | 292.7x | Above the sector median of 16.5x (No. 34 from the lowest) |
| PBR | 1.43x | Below the sector median of 1.86x (No. 25 from the lowest) |
| ROE | 0.49% | No. 33 in the sector (highest first); median 4.17% |
| Market cap | ¥58.7 bn | No. 29 in the sector (largest first) |
Ranks among stocks in the same Tokyo Stock Exchange sector (33 sectors). PER and PBR of zero or below (losses, negative equity) are excluded and ranked from the lowest.
Price milestones
| 52-week high | ¥783 | 2025/11/28 |
|---|---|---|
| 52-week low | ¥445 | 6/26 |
| Current position | 10.4% | Where the low is 0% and the high is 100% (close on 11/20: ¥480) |
| Year to date | -32.6% | No. 56 of 77 in the sector (best first) |
| 1 year | -24.4% |
Based on closing prices (adjusted for stock splits, excluding dividends).
Kabutaro's ranking history
| Top 50 gainers | 2 times | Latest: 10/30 (No. 34) |
|---|
Gainers and losers have been recorded since 9/2026.
Calculated as of 2026/11/20 17:30 JST. Updated every business day in the evening.
Recent disclosures (TDnet, in Japanese)
- 10/29 15:302027年3月期 第2四半期(中間期)決算短信〔日本基準〕(連結)
- 10/29 15:302027年3月期 第2四半期 決算説明会 プレゼンテーション資料
- 10/02 15:30ハンター症候群の新規治療剤JR-141 欧米等における商業化に関するライセンス契約締結のお知らせ
Filings from the past 12 months (3).
Posts
This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.
No posts yet. Be the first to write something.
Write on the JCR Pharmaceuticals Co.,Ltd. board
More Japanese stocks in English
- TOWA PHARMACEUTICAL CO.,LTD.4553
- Fuji Pharma Co.,Ltd.4554
- CHUKYO IYAKUHIN CO.,LTD.4558
- ZERIA PHARMACEUTICAL CO.,LTD.4559
- Value Soft Holdings Corporation455A
- AnGes,Inc.4563
- OncoTherapy Science,Inc.4564
- Nxera Pharma Co.,Ltd.4565
- KYORIN Pharmaceutical Co.,Ltd.4569
- HUMAN MADE Inc.456A
- Immuno-Biological Laboratories Co.,Ltd.4570
- Nano Holdings,Inc.4571